Hints and tips:
Showing results for RANDALL MERCKS
...Randall Schatzman, Alder’s chief executive, disagrees, arguing that up to 13m US patients could benefit from taking one of the new migraine drugs....
...Pfizer shares, which have lagged behind Merck’s, slipped 0.3 per cent to $34.48....
...Elsewhere in the sector Merck was up 1.6 per cent to $33.30 while Forest Laboratories rose 4.3 per cent to $32.48. The S&P healthcare index was up 0.7 per cent....
International Edition